prof. Jo Dehoorne

Miscellaneous
open access

De novo CUL3 variant in a child presenting with hypertension and kidney failure

Lieselot Peremans (UGent) , Amélie Dendooven (UGent) , Erika D'haenens (UGent) , Sofie Symoens (UGent) , Bert Callewaert (UGent) , Laurenz Decock, Lies Vantomme (UGent) , Sarah Vergult (UGent) , Jo Dehoorne (UGent) , Lien Dossche (UGent) , et al.

(2025) KIDNEY INTERNATIONAL REPORTS. 10(7). p.2484-2487

Add to list

Identification of a 5-plex cytokine signature that differentiates patients with multiple systemic inflammatory diseases

Levi Hoste (UGent) , Bram Meertens (UGent) , Benson Ogunjimi, Vito Sabato, Khadija Guerti, Jeroen van der Hilst, Jeroen Bogie, Rik Joos, Karlien Claes (UGent) , Veronique Debacker (UGent) , et al.

(2025) INFLAMMATION. 48. p.2182-2197

Add to list

Journal Article
A1
open access

Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management : a 10-year cohort study

Eva Degraeuwe (UGent) , Elke Gasthuys (UGent) , Evelien Snauwaert (UGent) , Lien Dossche (UGent) , Agnieszka Prytula-Ebels (UGent) , Jo Dehoorne (UGent) , An Vermeulen (UGent) , Johan Vande Walle (UGent) and Ann Raes (UGent)

(2024) PEDIATRIC NEPHROLOGY. 40(3). p.797-809

Add to list

Journal Article
A1
open access

Summary of research : ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Jelena Vojinović, Ivan Foeldvari, Jo Dehoorne (UGent) , Violeta Panaviene, Gordana Susic, Gerd Horneff, Valda Stanevica, Katarzyna Kobusinska, Zbigniew Zuber, Bogna Dobrzyniecka, et al.

(2024) RHEUMATOLOGY AND THERAPY. 11(6). p.1437-1440

Add to list

Age-dependent signature of serum inflammatory cytokines in healthy children and young adults

Maarten Buytaert (UGent) , Rachida El Kaddouri, Levi Hoste (UGent) , Bram Meertens (UGent) , Simon Tavernier, Karlien Claes (UGent) , Veronique Debacker (UGent) , Jo Dehoorne (UGent) and Filomeen Haerynck (UGent)

(2024) JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 44(8). p.372-378

Add to list

The hyperPed-COVID international registry : impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

Roberta Caorsi, Alessandro Consolaro, Camilla Speziani, Betul Sozeri, Kadir Ulu, Enrique Faugier-Fuentes, Hector Menchaca-Aguayo, Seza Ozen, Seher Sener, Shahana Akhter Rahman, et al.

(2024) JOURNAL OF AUTOIMMUNITY. 147.

Add to list

Made in Belgium : exploring the immune horizon : systemic inflammatory diseases in the era of SARS-CoV-2 and beyond

Levi Hoste (UGent) , Filomeen Haerynck (UGent) , Jo Dehoorne (UGent) and Simon Tavernier (UGent)

(2024) BELGIAN JOURNAL OF PAEDIATRICS. 26(1). p.73-75

Add to list

Real world data on the use of lisinopril over 10 years within pediatric nephrology

Eva Degraeuwe (UGent) , Ann Raes (UGent) , Elke Gasthuys (UGent) , Evelien Snauwaert (UGent) , Lien Dossche (UGent) , Agnieszka Prytula-Ebels (UGent) , Jo Dehoorne (UGent) , An Vermeulen (UGent) and Johan Vande Walle (UGent)

(2024) BVK-SBP Congress 2024, Abstracts.

Add to list

Age-dependent signature of serum inflammatory cytokines IL-1Ra, IL-1β, IL-6, IL-18, TNF-α, CXCL9 and CXCL10 in healthy children

Maarten Buytaert (UGent) , Rachida El Kaddouri, Levi Hoste (UGent) , Bram Meertens (UGent) , Simon Tavernier (UGent) , Veronique Debacker (UGent) , Karlien Claes (UGent) , Jo Dehoorne (UGent) and Filomeen Haerynck (UGent)

(2024) BVK-SBP Congress 2024, Abstracts.

Add to list

Journal Article
A1
open access

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Jelena Vojinović, Ivan Foeldvari, Jo Dehoorne (UGent) , Violeta Panaviene, Gordana Susic, Gerd Horneff, Valda Stanevicha, Katarzyna Kobusinska, Zbigniew Zuber, Bogna Dobrzyniecka, et al.

(2024) RHEUMATOLOGY. 63(1). p.140-148

Academic Bibliography

prof. Jo Dehoorne

De novo CUL3 variant in a child presenting with hypertension and kidney failure

Identification of a 5-plex cytokine signature that differentiates patients with multiple systemic inflammatory diseases

Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management : a 10-year cohort study

Summary of research : ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Age-dependent signature of serum inflammatory cytokines in healthy children and young adults

The hyperPed-COVID international registry : impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

Made in Belgium : exploring the immune horizon : systemic inflammatory diseases in the era of SARS-CoV-2 and beyond

Real world data on the use of lisinopril over 10 years within pediatric nephrology

Age-dependent signature of serum inflammatory cytokines IL-1Ra, IL-1β, IL-6, IL-18, TNF-α, CXCL9 and CXCL10 in healthy children

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Contents

Support

Contact